Finance

Lists
Outlook: 57.6% bullish·3.0% bearish
Go to analysis
WELL:NYSE
Welltower Inc
$239.00
+1.88%
(+4.40) 1D
$239.00
0.00% (0.00)
After hours
Closed: Nov 2, 4:02:46 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for WELL...
Open
$234.66
High
$239.16
Low
$234.18
Mkt. cap
175.33B
Avg. vol.
2.75M
Volume
2.69M
Dividend
1.33%
Quarterly dividend
$0.80
Ex-dividend date
Aug 12, 2026
P/E ratio
103.14
52-wk high
$255.20
52-wk low
$179.24
EPS
$2.32
Beta
0.75
Shares outstanding
733.61M
No. of employees
712
Open
$234.66
High
$239.16
Low
$234.18
Mkt. cap
175.33B
Avg. vol.
2.75M
Volume
2.69M
Dividend
1.33%
Quarterly dividend
$0.80
Ex-dividend date
Aug 12, 2026
P/E ratio
103.14
52-wk high
$255.20
52-wk low
$179.24
EPS
$2.32
Beta
0.75
Shares outstanding
733.61M
No. of employees
712
News stories
From web sources and news partners
Profile
Welltower Inc. is an American real estate investment trust that invests in healthcare facilities such as retirement and nursing homes, and outpatient medical clinics. As of December 31, 2022, the company had investments in approximately 3,000 properties, all of which were in the United States, Canada, and the United Kingdom. The company’s stock is listed in the S&P 500. Wikipedia
About Welltower Inc
CEOShankh Mitra
Employees712
Founded1970
HeadquartersToledo, Ohio, United States
SectorReal estate investment trust
Websitewelltower.com
Analyst ratings
Based on 15 analysts giving stock ratings to WELL in the past 3 months
Strong buy
Buy
14
Hold
1
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for WELL in the last 3 months.
Highest
Current $239.00
$292.00 (+22.18%)
Average
$246.00 (+2.93%)
Lowest
$6.07 (-97.46%)
Analyst
Recommendation
Action
Price target
Projected
Date
Farrell Granath
Bank of America Securities
Buy
Reiterated
$292.00
+22.2%
11/02/2026
Dave Rodgers
Raymond James
Buy
Maintained
$263.00
+10%
10/29/2026
Richard Anderson
Cantor Fitzgerald
Buy
Reiterated
$258.00
+7.9%
10/29/2026
Zhiger Kurmet
Freedom Capital Markets
Buy
Upgraded
$255.00
+6.7%
10/28/2026
James Kammert
Evercore ISI
Buy
Maintained
$256.00
+7.1%
10/27/2026
Nicholas Yulico
Scotiabank
Buy
Maintained
$251.00
+5%
10/27/2026
James Feldman
Wells Fargo
Buy
Maintained
$268.00
+12.1%
10/27/2026
Ronald Kamdem
Morgan Stanley
Buy
Maintained
$251.00
+5%
10/27/2026
John Kilichowski
Wells Fargo
Buy
Reiterated
$268.00
+12.1%
10/19/2026
Michael Goldsmith
UBS
Buy
Maintained
$269.00
+12.6%
10/13/2026
Richard Hightower
Barclays
Hold
Maintained
$246.00
+2.9%
10/13/2026
Juan C. Sanabria
BMO Capital
Buy
Reiterated
$265.00
+10.9%
10/02/2026
Michael Mueller
J.P. Morgan
Buy
Upgraded
$260.00
+8.8%
09/24/2026
Joe Dickstein
Jefferies
Buy
Initiated
$275.00
+15.1%
09/15/2026
Justin Keywood
Stifel Nicolaus
Buy
Maintained
CA$8.50
-96.4%
08/05/2026
Austin Wurschmidt
KeyBanc
Buy
Maintained
$275.00
+15.1%
08/04/2026
Nicholas Joseph
Citi
Buy
Maintained
$275.00
+15.1%
07/31/2026
Michael Carroll
RBC Capital
Buy
Maintained
$260.00
+8.8%
07/31/2026
Vikram Malhotra
Mizuho Securities
Buy
Maintained
$260.00
+8.8%
07/22/2026
Unknown Analyst
Wells Fargo
Buy
Reiterated
$268.00
+12.1%
07/15/2026
Unknown Analyst
Raymond James
Buy
Initiated
$226.00
-5.4%
06/16/2026
Jonathan Petersen
Jefferies
Buy
Maintained
$248.00
+3.8%
05/12/2026
Andy Barish
Jefferies
Buy
Maintained
$375.00
+56.9%
04/13/2026
Last report
Oct 27, 2026
Fiscal period
Q3 2026
$0.67 / $0.71
-6.14%miss
Revenue / Est. (USD)
3.72B / 3.75B
-0.98%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
3.18B
3.35B
3.54B
3.72B
Cost of goods sold
1.93B
2.06B
2.15B
2.25B
Cost of revenue
1.93B
2.06B
2.15B
2.25B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.56B
67.47M
67.49M
67.17M
Operating expense
2.15B
690.23M
805.25M
773.96M
Total operating expenses
4.08B
2.75B
2.96B
3.02B
Operating income
-897.07M
604.65M
587.03M
695.57M
Other non operating income
-120.19M
-61.14M
-56.93M
-124.69M
EBT including unusual items
112.78M
763.96M
401.00M
421.94M
EBT excluding unusual items
-1.22B
349.11M
330.22M
347.54M
Income tax expense
-4.98M
11.63M
-61.98M
7.12M
Effective tax rate
-4.42%
1.52%
-15.46%
1.69%
Other operating expenses
-
-
-
-
Net income
96.44M
728.67M
445.00M
396.59M
Net profit margin
3.03%
21.74%
12.55%
10.67%
Earnings per share
0.55
0.55
0.54
0.67
Interest and investment income
-
-
-
-
Interest expense
-203.78M
-192.72M
-181.91M
-192.66M
Net interest expenses
-203.78M
-192.72M
-181.91M
-192.66M
Depreciation and amortization charges
594.15M
622.75M
737.76M
706.79M
EBITDA
-290.19M
1.24B
1.34B
1.41B
Gain or loss from assets sale
-1.38B
-420.40M
-98.54M
-114.68M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps